文献速递神经肿瘤小儿神经外科与脑积水

儿童脑肿瘤幸存者注意缺陷多动障碍的临床诊断

Clinical diagnosis of attention-deficit/hyperactivity disorder in survivors of pediatric brain tumors.
PubMed 文献 · J Neurooncol · 2019-04-13

这项回顾性研究分析了528例儿童脑肿瘤幸存者,发现13.1%有ADHD临床诊断,19.9%有ADHD症状但未诊断,12.1%使用ADHD药物。ADHD诊断与诊断时年龄较小(p=0.05)和幕上肿瘤位置(p=0.001)相关,与性别、肿瘤类型或治疗类型无关。幸存者ADHD风险增加,尤其年幼诊断和幕上肿瘤者。

要点

  • 儿童脑肿瘤幸存者ADHD诊断率13.1%,症状发生率19.9%,均高于一般人群。
  • ADHD诊断与诊断时年龄较小和幕上肿瘤位置相关。
  • 部分幸存者可能从行为或药物治疗中获益以优化功能。

核心结论

  • 脑肿瘤幸存者ADHD及相关症状风险增加,风险最高见于诊断时年龄较小和幕上肿瘤的幸存者。

研究设计与样本

  • 回顾性图表综述,纳入2000至2015年诊断的528例脑肿瘤幸存者,诊断时至少6岁且距肿瘤定向治疗结束或诊断至少2年(若未接受干预)。

主要发现

  • ADHD诊断与诊断时年龄较小相关(p=0.05),与幕上肿瘤位置相关(p=0.001)。
  • ADHD诊断与性别、肿瘤类型或治疗类型无关。

关键数值与推荐

  • 幸存者中55.7%为男性,诊断时平均年龄8.15±4.4岁(范围0.0-16.0岁)。
  • 最常见诊断:低级别胶质瘤、髓母细胞瘤、颅咽管瘤;52.5%肿瘤位于幕上。
  • 81.3%接受手术,40.0%接受放疗,36.6%接受化疗。

临床怎么用

  • 对儿童脑肿瘤幸存者,尤其诊断时年龄较小或幕上肿瘤者,应关注ADHD症状并考虑评估。
  • 部分幸存者可能受益于行为或药物治疗以优化功能。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Survivors of pediatric brain tumors often have neurodevelopmental late effects, such as inattention. Symptoms may mirror those of attention-deficit/hyperactivity disorder (ADHD), which affects ~ 5-8% of the general population. This retrospective study of survivors followed at a large tertiary care center examined the prevalence of a clinical diagnosis of ADHD, and risk factors associated with ADHD diagnosis and ADHD-related medication use. METHODS: A retrospective chart review of brain tumor survivors (n = 528), diagnosed between 2000 and 2015, who were at least 6 years old and 2 years from the end of tumor-directed therapy or from diagnosis, if no interventions were received. Clinical and demographic data were extracted from the medical record. RESULTS: Survivors were 55.7% male with mean age 8.15 ± 4.4 (0.0-16.0) years at brain tumor diagnosis. The most common diagnoses were low-grade glioma, medulloblastoma, and craniopharyngioma, with 52.5% of tumors supratentorial. Of the survivors, 81.3% received surgery, 40.0% radiation therapy, and 36.6% chemotherapy. Sixty-nine survivors (13.1%) had ADHD diagnoses, 105 (19.9%) had symptoms of ADHD without diagnoses, and 64 (12.1%) had ADHD medication use. ADHD diagnosis was associated with younger age at tumor diagnosis (p = 0.05) and supratentorial tumor location (p = 0.001). ADHD diagnosis was not associated with gender, tumor type, or treatment type. CONCLUSIONS: Survivors of brain tumors are at increased risk of ADHD and related symptoms. The greatest increase in risk occurs for survivors with diagnoses at younger ages and supratentorial tumors. Additional research is warranted, as select survivors may benefit from behavioral or pharmacologic ADHD treatments to optimize functioning.

来源:J Neurooncol,查看原文。版权归原作者所有。

引用

  1. Shabason EK, Brodsky C, Baran J, et al. Clinical diagnosis of attention-deficit/hyperactivity disorder in survivors of pediatric brain tumors. J Neurooncol. 2019. PMID: 30982198. doi:10.1007/s11060-019-03165-4

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。